Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Differential Evasion of Delta and Omicron Immunity and Enhanced Fusogenicity of SARS-CoV-2 Omicron BA.4/5 and BA.2.12.1 Subvariants
Panke Qu, Julia N. Faraone, John P. Evans, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 19

Showing 19 citing articles:

Enhanced evasion of neutralizing antibody response by Omicron XBB.1.5, CH.1.1, and CA.3.1 variants
Panke Qu, Julia N. Faraone, John P. Evans, et al.
Cell Reports (2023) Vol. 42, Iss. 5, pp. 112443-112443
Open Access | Times Cited: 144
Origin, virological features, immune evasion and intervention of SARS-CoV-2 Omicron sublineages
Shuai Xia, Lijue Wang, Yun Zhu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 134
Spike mutations contributing to the altered entry preference of SARS-CoV-2 omicron BA.1 and BA.2
Bingjie Hu, Jasper Fuk‐Woo Chan, Huan Liu, et al.
Emerging Microbes & Infections (2022) Vol. 11, Iss. 1, pp. 2275-2287
Open Access | Times Cited: 68
Immune evasion and membrane fusion of SARS-CoV-2 XBB subvariants EG.5.1 and XBB.2.3
Julia N. Faraone, Panke Qu, Negin Goodarzi, et al.
Emerging Microbes & Infections (2023) Vol. 12, Iss. 2
Open Access | Times Cited: 68
SARS-CoV-2 Omicron variants: burden of disease, impact on vaccine effectiveness and need for variant-adapted vaccines
Shanti Pather, Shabir A. Madhi, Benjamin J. Cowling, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 49
Extraordinary Evasion of Neutralizing Antibody Response by Omicron XBB.1.5, CH.1.1 and CA.3.1 Variants
Panke Qu, Julia N. Faraone, John P. Evans, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 42
Determinants and Mechanisms of the Low Fusogenicity and High Dependence on Endosomal Entry of Omicron Subvariants
Panke Qu, John P. Evans, Chaitanya Kurhade, et al.
mBio (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 25
Clinical development of variant-adapted BNT162b2 COVID-19 vaccines: the early Omicron era
Shanti Pather, Alexander Muik, Ruben Rizzi, et al.
Expert Review of Vaccines (2023) Vol. 22, Iss. 1, pp. 650-661
Open Access | Times Cited: 15
Immune Evasion of SARS-CoV-2 Omicron Subvariants
Hanzhong Ke, Matthew Chang, Wayne A. Marasco
Vaccines (2022) Vol. 10, Iss. 9, pp. 1545-1545
Open Access | Times Cited: 26
A Heterologous V-01 or Variant-Matched Bivalent V-01D-351 Booster following Primary Series of Inactivated Vaccine Enhances the Neutralizing Capacity against SARS-CoV-2 Delta and Omicron Strains
Zhiren Zhang, Qiaren He, Wei Zhao, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 14, pp. 4164-4164
Open Access | Times Cited: 22
The humoral and cellular immune evasion of SARS-CoV-2 Omicron and sub-lineages
Tiandan Xiang, Junzhong Wang, Xin Zheng
Virologica Sinica (2022) Vol. 37, Iss. 6, pp. 786-795
Open Access | Times Cited: 20
The Epidemiological Features of the SARS-CoV-2 Omicron Subvariant BA.5 and Its Evasion of the Neutralizing Activity of Vaccination and Prior Infection
Dandan Tian, Wenjian Nie, Yanhong Sun, et al.
Vaccines (2022) Vol. 10, Iss. 10, pp. 1699-1699
Open Access | Times Cited: 17
Antibody-dependent cellular cytotoxicity against SARS-CoV-2 Omicron sub-lineages is reduced in convalescent sera regardless of infecting variant
Simone I. Richardson, Prudence Kgagudi, Nelia P. Manamela, et al.
Cell Reports Medicine (2022) Vol. 4, Iss. 1, pp. 100910-100910
Open Access | Times Cited: 14
Immune Evasion and Membrane Fusion of SARS-CoV-2 XBB Subvariants EG.5.1 and XBB.2.3
Julia N. Faraone, Panke Qu, Negin Goodarzi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 8
Determinants and Mechanisms of the Low Fusogenicity and Endosomal Entry of Omicron Subvariants
Panke Qu, John P. Evans, Chaitanya Kurhade, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 7
Raman Fingerprints of SARS-CoV-2 Omicron Subvariants: Molecular Roots of Virological Characteristics and Evolutionary Directions
Giuseppe Pezzotti, Eriko Ohgitani, Yuki Fujita, et al.
ACS Infectious Diseases (2023) Vol. 9, Iss. 11, pp. 2226-2251
Open Access | Times Cited: 2
SARS-CoV-2 Intermittent Virulence as a Result of Natural Selection
Alberto Rubio‐Casillas, Elrashdy M. Redwan, Vladimir N. Uversky
COVID (2022) Vol. 2, Iss. 8, pp. 1089-1101
Open Access | Times Cited: 4
Fc effector activity and neutralization against SARS-CoV-2 BA.4 is compromised in convalescent sera, regardless of the infecting variant
Simone I. Richardson, Prudence Kgagudi, Nelia P. Manamela, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 3
SARS-CoV-2 delta (B.1.617.2) spike protein adjuvanted with Alum-3M-052 enhances antibody production and neutralization ability
Hong Huang, Zhongcheng Zhou, Xinxin Xiong, et al.
Frontiers in Public Health (2023) Vol. 10
Open Access | Times Cited: 1
Page 1

Scroll to top